American Journal of Clinical Nutrition, Vol 33, 2079-2087, Copyright © 1980 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Leukocyte ascorbic acid and its relationship to coronary artery disease in man

J Ramirez and NC Flowers

The ascorbic acid level of the leukocytes in patients with coronary artery disease was compared to the ascorbic acid level of the leukocytes in patients without coronary artery disease as demonstrated by coronary arteriography. The leukocyte ascorbic acid level was found significantly lower in patients with coronary arteriography. The leukocyte ascorbic acid level was found significantly lower in patients with coronary atherosclerosis (P < 0.001). There was also significant difference in the leukocyte ascorbic acid levels among patients with abnormal coronary arteriograms who smoked compared to those who did not. The anatomical changes secondary to atherosclerotic disease, and mainly those changes related to the ground substance, have been shown to be the changes that have been observed in patients with ascorbic acid deficiency. From the present study, with its limitations, it is suggested that ascorbic acid may play a role in the pathogenesis of atherosclerosis, and although not implicated as an etiological factor in coronary artery disease, it suggests that a closer look at its possible role in the pathogenesis and progression of coronary artery disease is warranted.

This article has been cited by other articles:

				J. H. Dwyer, M. J. Paul-Labrador, J. Fan, A. M. Shircore, C. N. B. Merz, and K. M. Dwyer Progression of Carotid Intima-Media Thickness and Plasma Antioxidants: The Los Angeles Atherosclerosis Study Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 313 - 319. [Abstract] [Full Text]

				K. M. Fairfield and R. H. Fletcher Vitamins for Chronic Disease Prevention in Adults: Scientific Review JAMA, June 19, 2002; 287(23): 3116 - 3126. [Abstract] [Full Text] [PDF]

				J. A. Simon, E. S. Hudes, and J. A. Tice Relation of Serum Ascorbic Acid to Mortality Among US Adults J. Am. Coll. Nutr., June 1, 2001; 20(3): 255 - 263. [Abstract] [Full Text] [PDF]

				S. J Padayatty and M. Levine Vitamin C and myocardial infarction: the heart of the matter Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1027 - 1028. [Full Text] [PDF]

				N. Gokce, J. F. Keaney Jr, B. Frei, M. Holbrook, M. Olesiak, B. J. Zachariah, C. Leeuwenburgh, J. W. Heinecke, and J. A. Vita Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease Circulation, June 29, 1999; 99(25): 3234 - 3240. [Abstract] [Full Text] [PDF]

				M. Levine, S. C. Rumsey, R. Daruwala, J. B. Park, and Y. Wang Criteria and Recommendations for Vitamin C Intake JAMA, April 21, 1999; 281(15): 1415 - 1423. [Abstract] [Full Text] [PDF]

				M. N. Diaz, B. Frei, J. A. Vita, and J. F. Keaney Antioxidants and Atherosclerotic Heart Disease N. Engl. J. Med., August 7, 1997; 337(6): 408 - 416. [Full Text] [PDF]

				R. Heller, A. Unbehaun, B. Schellenberg, B. Mayer, G. Werner-Felmayer, and E. R. Werner L-Ascorbic Acid Potentiates Endothelial Nitric Oxide Synthesis via a Chemical Stabilization of Tetrahydrobiopterin J. Biol. Chem., January 5, 2001; 276(1): 40 - 47. [Abstract] [Full Text] [PDF]